Comment by qgin

Price is only slightly related to production costs. It’s much more about all the work that goes into getting something like this from basic science to trials to approval (and all the other drugs that fail along the way).

In the current model, pharma only stays in business by recouping all of the during the patent protected period of any drug that makes it to market.